Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06118346 · ClinicalTrials.gov registry record · NA

A Female-Specific CBT Group for Veteran Women With Alcohol Use Disorder in VA Primary Care Settings

A NA study of Alcohol Use Disorder and Risky Health Behavior, sponsored by University of Massachusetts, Worcester.

Recruiting
Registry status
NA
Development phase
162
Enrollment target
1
Study location

NCT06118346 is a NA study of Alcohol Use Disorder and Risky Health Behavior that is actively recruiting participants, run by University of Massachusetts, Worcester. The registered enrollment target is 162 participants, below the 328-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (51% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06118346, a NA study of Alcohol Use Disorder and Risky Health Behavior, is actively recruiting participants, sponsored by University of Massachusetts, Worcester.

RECRUITING
Registry status
NA
Development phase
162 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate a Female-Specific Cognitive Behavioral Therapy (CBT) Group as treatment for Alcohol Use Disorder among Veteran women.

Interventions

  • BEHAVIORAL Usual Care
  • BEHAVIORAL Female-Specific Cognitive Behavioral Therapy (FS-CBT)

Study Locations (1)

New York

  • VA New York Harbor Healthcare System - New York

Trial Details

FieldValue
Enrollment Target 162 participants
Start Date 2023-02-24
Est. Completion 2027-01-30
Phase NA

What the Registry Record Tells You About NCT06118346

The ClinicalTrials.gov registry entry for NCT06118346 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 162 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 328-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (51% lower). The listed sponsor is University of Massachusetts, Worcester, which has 240 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Alcohol Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.

NCT06118346 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT06118346 about?

NCT06118346 is a clinical study titled "A Female-Specific CBT Group for Veteran Women With Alcohol Use Disorder in VA Primary Care Settings". The purpose of this study is to evaluate a Female-Specific Cognitive Behavioral Therapy (CBT) Group as treatment for Alcohol Use Disorder among Veteran women.

What is the current status of trial NCT06118346?

This trial is currently recruiting. It is a NA study. The enrollment target is 162 participants. The study started on 2023-02-24. Estimated completion is 2027-01-30.

What conditions does trial NCT06118346 study?

This clinical trial studies the following conditions: Alcohol Use Disorder, Risky Health Behavior.

What interventions are being tested in trial NCT06118346?

The interventions under investigation include: Usual Care (BEHAVIORAL), Female-Specific Cognitive Behavioral Therapy (FS-CBT) (BEHAVIORAL).

Who is sponsoring clinical trial NCT06118346?

This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06118346 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alcohol Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.